These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 10053049)
1. Identification of a pharmacologically active metabolite of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil. Schütz E; Shipkova M; Armstrong VW; Wieland E; Oellerich M Clin Chem; 1999 Mar; 45(3):419-22. PubMed ID: 10053049 [No Abstract] [Full Text] [Related]
2. Inhibition of inosine monophosphate dehydrogenase activity by the plasma of heart transplant recipients receiving mycophenolate mofetil. Griesmacher A; Weigel G; Seebacher G; Mallinger R; Laufer G; Müller MM Adv Exp Med Biol; 1998; 431():537-41. PubMed ID: 9598124 [No Abstract] [Full Text] [Related]
3. Age-related variability of mycophenolate mofetil exposure in stable pediatric liver transplant recipients and influences of donor characteristics. Parant F; Rivet C; Boulieu R; Gagnieu MC; Dumortier J; Boillot O; Lachaux A Ther Drug Monit; 2009 Dec; 31(6):727-33. PubMed ID: 19881404 [TBL] [Abstract][Full Text] [Related]
4. Induction of inosine monophosphate dehydrogenase activity after long-term treatment with mycophenolate mofetil. Sanquer S; Breil M; Baron C; Dhamane D; Astier A; Lang P Clin Pharmacol Ther; 1999 Jun; 65(6):640-8. PubMed ID: 10391669 [TBL] [Abstract][Full Text] [Related]
5. Effect of mycophenolate mofetil on IMP dehydrogenase after the first dose and after long-term treatment in renal transplant recipients. Glander P; Hambach P; Braun KP; Fritsche L; Waiser J; Mai I; Neumayer HH; Budde K Int J Clin Pharmacol Ther; 2003 Oct; 41(10):470-6. PubMed ID: 14703953 [TBL] [Abstract][Full Text] [Related]
6. Improved high-performance liquid chromatographic assay for the measurement of mycophenolic acid in human plasma. Li S; Yatscoff RW Transplant Proc; 1996 Apr; 28(2):938-40. PubMed ID: 8623471 [No Abstract] [Full Text] [Related]
10. Quantification of mycophenolic acid in plasma samples collected during and immediately after intravenous administration of mycophenolate mofetil. Shipkova M; Armstrong VW; Kiehl MG; Niedmann PD; Schütz E; Oellerich M; Wieland E Clin Chem; 2001 Aug; 47(8):1485-8. PubMed ID: 11468247 [No Abstract] [Full Text] [Related]
11. Pemphigus foliaceus successfully treated with mycophenolate mofetil as a steroid-sparing agent. Katz KH; Marks JG; Helm KF J Am Acad Dermatol; 2000 Mar; 42(3):514-5. PubMed ID: 10688729 [TBL] [Abstract][Full Text] [Related]